How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Kandzari DE, Weber MA, Pathak A et al. (2024) Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation.

    2. Pathak A, Rudolph UM, Saxena M et al. (2023) Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. DOI: 10.4244/EIJ-D-23-00088

    3. Mahfoud F, Renkin J, Sievert H et al. (2020) Alcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension. JACC. Cardiovascular interventions 13(4): 471-84

    4. Mahfoud F, Sievert H, Bertog S et al. (2021) Long-term results up to 12 months after catheter-based alcohol-mediated renal denervation for treatment of resistant hypertension. Circulation: Cardiovascular Interventions: 918-26

    5. Janas A, Krol M, Hochul M et al. (2020) Evaluation of transcatheter alcohol-mediated perivascular renal denervation to treat resistant hypertension. Journal of Clinical Medicine 9(6): 1-12

    6. Fischell TA, Ebner A, Gallo S et al. (2016) Transcatheter alcohol-mediated perivascular renal denervation with the peregrine system: first-in-human experience. JACC. Cardiovascular interventions 9(6): 589-98